PRLD Company Information
Prelude Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
Delaware, USA
Prelude Therapeutics Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Prelude Therapeutics Inc
Did you know?
Holds 2.2x more cash than debt — a strong balance sheet.
Current Price
$4.74
+0.85%GoodMoat Value
$0.97
79.6% overvaluedProfile
Valuation (TTM)
Market Cap$297.98M
P/E-2.99
EV—
P/B4.34
Shares Out62.87M
P/Sales24.55
Revenue$12.14M
EV/EBITDA—
Prelude Therapeutics Inc (PRLD) Company Profile
PRLD Key Officers
Key officers data coming soon
PRLD Company Profile
Prelude Therapeutics Inc (PRLD) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in Delaware, USA.
Prelude Therapeutics Inc
Market cap is $297.98M. There are 62.9M shares outstanding.
See the full Prelude Therapeutics Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if PRLD is a good investment.